Alcohol use disorders in adolescents: Epidemiology, diagnosis, psychosocial interventions, and pharmacological treatment

Pediatric Drugs

Volumn 4, Issue 8, 2002, Pages 493-502

  Clark, Duncan B ^a   Bukstein, Oscar ^a   Cornelius, Jack ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; ALCOHOL; AMFEBUTAMONE; ANXIOLYTIC AGENT; CAFFEINE; CANNABIS; COCAINE; DEXAMPHETAMINE; FLUOXETINE; HYPNOTIC AGENT; METHYLPHENIDATE; NICOTINE; OPIATE; PEMOLINE; PHENCYCLIDINE; PSYCHEDELIC AGENT; SEDATIVE AGENT; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

ADOLESCENT; ALCOHOL ABUSE; ALCOHOL CONSUMPTION; ALCOHOL WITHDRAWAL; ALCOHOLISM; ATTENTION DEFICIT DISORDER; AVERSION THERAPY; CLINICAL TRIAL; COMORBIDITY; DEPRESSION; HUMAN; PRIORITY JOURNAL; PSYCHOSOCIAL CARE; REVIEW; SUBSTANCE ABUSE;

ADOLESCENT; ADOLESCENT PSYCHOLOGY; ALCOHOL DETERRENTS; ALCOHOL DRINKING; ALCOHOLIC INTOXICATION; ALCOHOLISM; HUMANS; PSYCHOLOGY; PSYCHOTHERAPY;

EID: 0036344327     PISSN: 11745878     EISSN: None     Source Type: Journal    
DOI: 10.2165/00128072-200204080-00002     Document Type: Review

References (88)

1. Young people and alcohol: An international insight
2. An epidemiological study of disorders in late childhood and adolescence (I): Age- and gender-specific prevalence
3. Psychiatric comorbidity with problematic alcohol use in high school students
4. Summary of the practice parameters for the assessment and treatment of children and adolescents with substance use disorders
5. Early adolescent gateway drug use in sons of fathers with substance use disorders
6. Psychopathology, substance use and substance related problems during early adolescence: A survival analysis
7. Childhood antisocial behavior and adolescent alcohol use disorders
8. Measuring risks and outcomes in substance use disorders prevention research
9. Early adult outcomes of adolescent binge drinking: Person- and variable-centered analyses of binge drinking trajectories
10. Patterns of DSM-IV alcohol abuse and dependence symptoms in adolescent drinkers
11. Toward the DSM-V: A withdrawal-gate model of alcohol abuse and dependence
12. Adolescent vs adult onset and the development of substance use disorders in males
13. Adolescents are not adults: Developmental considerations in alcohol users
14. Family functioning and adolescent alcohol use disorders
15. PTSD, depression, alcohol use disorders, and quality of life in adolescents
16. A neuropsychologic profile of adolescent alcoholics
17. Substance dependence, family history of alcohol dependence, and neuropsychological functioning in adolescence
18. Neurocognitive functioning of adolescents: Effects of protracted alcohol use
19. Neuropsychological correlates of adolescent substance abuse: Four-year outcomes
20. Hippocampal volume in adolescent onset alcohol use disorders
21. Patterns of polydrug use in adolescent alcohol abusers
22. Clinical correlates of heavy tobacco use among adolescents
23. Polydrug use in adolescent drinkers with and without DSM-IV alcohol abuse and dependence
24. Gender and comorbid psychopathology in adolescents with alcohol use disorders
25. Cannabis dependence, withdrawal, and reinforcing effects among adolescents with conduct symptoms and substance use disorders
26. Does cannabis use encourage other forms of illicit drug use
27. Psychopathology in adolescent alcohol abuse and dependence
28. Adolescent substance abuse and internalizing disorders
29. Comorbid mental disorders in adolescents with substance use disorders
30. Psychiatric assessment
31. Rapid relapse generally follows treatment for substance use disorders among adolescents
32. Adolescent alcohol and drug abuse and health
33. Specific alcoholic beverages and physical and mental health among adolescents
34. Health problems in adolescents with alcohol use disorders: Self-report, liver injury and physical examination findings
35. Diagnostic concordance of DSM-III, DSM-III-R, DSM-IV and ICD-10 alcohol diagnoses in adolescents
36. Assessment of alcohol tolerance in adolescents
37. Diagnostic orphans: Adolescents with alcohol symptomatology who do not qualify for DSM-IV abuse or dependence diagnoses
38. Diagnosis and assessment of alcohol use disorders among adolescents
39. Screening adolescents for problem drinking: Performance of brief screens against DSM-IV alcohol diagnoses
40. Outcome measures for substance use disorders
41. Identifying anxiety disorders in adolescents hospitalized for alcohol abuse or dependence
42. Schedule for affective disorders and schizophrenia for school-age children - Present and lifetime version (K-SADS-PL): Initial reliability and validity data
43. Inter-rater reliability of the SCID alcohol and substance use disorders section among adolescents
44. An overview of controlled studies of adolescent substance abuse treatment
45. Correlates of success following treatment for adolescent substance abuse
46. Pharmacological treatment of substance abuse disorders
47. Pharmacotherapy of adolescent AOD use disorders
48. Alcohol withdrawal
49. Withdrawal and dependency symptoms among adolescent alcohol and drug abusers
50. Pharmacological treatment of alcohol dependence: A review of the evidence
51. Disulfiram for alcohol use disorders in adolescents
52. The role of craving in alcohol use, dependence, and treatment
53. Naltrexone for alcoholic adolescents
54. Naltrexone for alcohol abuse
55. Acamprosate in alcohol dependence: How does it work
56. Efficacy of naltrexone and acamprosate for alcoholism treatment: A meta-analysis
57. A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression
58. Fluoxetine in depressed alcoholics: A double-blind, placebo-controlled trial
59. Fluoxetine in adolescents with major depression and an adolescent alcohol use disorder: An open label trial
60. A double-blind, placebo-controlled trial of sertraline in depressed adolescent alcoholics: A pilot study
61. AOD use and attention deficit/hyperactivity disorder
62. Pharmacotherapy of attention-deficit hyperactivity disorder across the life cycle
63. Equivalent effects of stimulant treatment for attention-deficit hyperactivity disorder during childhood and adolescence
64. Clinical efficacy of methylphenidate in conduct disorder with and without attention deficit hyperactivity disorder
65. Pharmacotherapy of attention-deficit hyperactivity disorder reduces risk for substance use disorder
66. Clinical trials in children: Problems and pitfalls
67. The ethics of drug research in children
68. Alcohol and drug abuse
69. Psychotherapies for adolescent substance abusers: A pilot study
70. Treatment outcomes for adolescent substance abuse at 4- and 7-month assessments
71. A comprehensive and comparative review of adolescent substance abuse treatment outcome
72. Multidimensional family therapy for adolescent drug abuse: Results of a randomized clinical trial
73. Effects of multisystemic therapy on drug use and abuse in serious juvenile offenders: A progress report from two outcome studies
74. Double-blind and placebo-controlled study of lithium for adolescent bipolar disorders with secondary substance dependency
75. Fluoxetine in drug-dependent delinquents with major depression: An open trial
76. Etiology of early age onset substance use disorder: A maturational perspective
77. Natural course of alcohol use disorders from adolescence to young adulthood
78. Alcohol abuse and dependence
79. Integrating person-centered and variable-centered analyses: Growth mixture modeling with latent trajectory classes